Comparison of protective effects of aspirin, d-penicillamine and vitamin E against high glucose-mediated toxicity in cultured endothelial cells

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1762, Issue 5, 2006, Pages 551-557

  Zhang, Jing ^a   Slevin, Mark ^a   Duraisamy, Yasotha ^a   Gaffney, John ^a   A Smith, Christopher ^a   Ahmed, Nessar ^a  

^a MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Advanced glycation endproduct; Antioxidant; Aspirin; d penicillamine; Diabetes; Endothelial cell; Glycation; Vitamin E; Wound healing

Indexed keywords

ACETYLSALICYLIC ACID; ADVANCED GLYCATION END PRODUCT; ALPHA TOCOPHEROL; BOVINE SERUM ALBUMIN; GLUCOSE; PENICILLAMINE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; AORTA; ARTERY ENDOTHELIUM; ARTICLE; CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CELL PROTECTION; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; COW; CYTOTOXICITY; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; GLYCATION; MONOLAYER CULTURE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ASPIRIN; CATTLE; CELL DEATH; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL CELLS; GLUCOSE; PENICILLAMINE; SERUM ALBUMIN, BOVINE; VITAMIN E;

ANIMALIA; BOS TAURUS;

EID: 33646093461     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2006.02.004     Document Type: Article

References (47)

1. Ahmed N. Advanced glycation endproducts-Role in pathology of diabetic complications. Diabetes Res. Clin. Pract. 67 (2005) 3-21
2. Martin A., Komada M.R., and Sane D.C. Abnormal angiogenesis in diabetes mellitus. Med. Res. Rev. 23 (2003) 117-145
3. Friedman E.A. Advanced glycosylated end products and hyperglycaemia in the pathogenesis of diabetic complications. Diabetes Care 22 (1999) B65-B71
4. Hunt J.V., Bottoms M.A., and Mitchinson M.J. Oxidative alterations in the experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation. Biochem. J. 291 (1993) 529-535
5. Naka Y., Bucciarelli L.G., Wendt T., Lee L.K., Rong L.L., Ramasamy R., Yan S.F., and Schmidt A.M. RAGE axis: animal models and novel insights into the vascular complications of diabetes. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1342-1349
6. Rojas A., and Morales M.A. Advanced glycation and endothelial functions: a link towards vascular complications in diabetes. Life Sci. 76 (2004) 715-730
7. Endemann D.H., and Schiffrin E.L. Endothelial dysfunction. J. Am. Soc. Nephrol. 15 (2004) 1983-1992
8. Lorenzi M., Cagliero E., and Toledo S. Glucose toxicity for human endothelial cells in culture: delayed replication, disturbed cell cycle and accelerated death. Diabetes 34 (1985) 621-627
9. Curcio F., and Ceriello A. Decreased cultured endothelial cell proliferation in high glucose medium is reversed by antioxidants: new insights on the pathophysiological mechanisms of diabetic vascular complications. In Vitro Cell. Dev. Biol. 28A (1992) 787-790
10. La Selva M., Beltramo E., Pagnozzi F., Bena E., Molinatti P.A., Molinatti G.M., and Porta M. Thiamine corrects delayed replication and decreases production of lactate and advanced glycation endproducts in bovine retinal and human umbilical vein endothelial cells cultured under high glucose conditions. Diabetologia 39 (1996) 1263-1268
11. Jiaojun D., Takami Y., Tanaka H., Yamaguchi R., Jingping G., Chun Q., Shuliang L., Shimazaki S., and Ogo K. Protective effects of a free radical scavenger, MCI-186, on high glucose-induced dysfunction of human dermal microvascular endothelial cells. Wound Rep. Regen. 12 (2004) 607-612
12. Dolgov V.V., Zaikina O.E., Bondarenko M.F., and Repin V.S. Aortic endothelium of alloxan diabetic rabbits. Diabetologia 22 (1982) 338-343
13. Mascardo R.N. The effects of hyperglycemia on the directed migration of wounded endothelial cell monolayers. Metabolism 37 (1988) 378-385
14. Hamuro M., Polan J., Natarajan M., and Mohan S. High glucose induced nuclear factor kappa B mediated inhibition of endothelial cell migration. Atherosclerosis 162 (2002) 277-287
15. Makita Z., Radoff S., Rayfield E.J., Yang Z., Skolnik E., Friedman E.A., Cerami A., and Vlassara H. Advanced glycosylation endproducts in patients with diabetic nephropathy. N. Engl. J. Med. 325 (1991) 836-842
16. Bucala R., and Vlassara H. Advanced glycosylation endproducts in diabetic renal and vascular disease. Am. J. Kidney Dis. 26 (1995) 875-888
17. Yui S., Sasaki T., Araki N., Horiuchi S., and Yamazaki M. Induction of macrophage growth by advanced glycation endproducts of the Maillard reaction. J. Immunol. 152 (1994) 1943-1949
18. McCarthy A., Etcheverry S.B., Bruzzone L., and Cortizo A.M. Effects of advanced glycation endproducts on the proliferation and differentiation of osteoblast-like cells. Mol. Cell. Biochem. 170 (1997) 43-51
19. Trachtman H., Futterweit S., Prenner J., and Hanon S. Antioxidants reverse the antiproliferative effects of high glucose and advanced glycation endproducts in cultured rat mesangial cells. Biochem. Biophys. Res. Commun. 199 (1994) 346-352
20. Duraisamy Y., Gaffney J., Slevin M., Smith C.A., Williamson K., and Ahmed N. Aminosalicylic acid reduces the antiproliferative effect of hyperglycaemia, advanced glycation endproducts and glycated basic fibroblast growth factor in cultured bovine aortic endothelial cells: comparison with aminoguanidine. Mol. Cell. Biochem. 246 (2003) 143-153
21. Yamagishi S., Hsu C.-C., Taniguchi M., Harada S., Yamamoto Y., Ohsawa K., Kobayashi K., and Yamamoto H. Receptor-mediated toxicity to pericytes of advanced glycosylation endproducts. Biochem. Biophys. Res. Commun. 213 (1995) 681-687
22. Sattar A., Kumar S., and West D.C. Does hyluronan have a role in endothelial cell proliferation of the synovium?. Semin. Arthritis Rheumatol. 22 (1992) 37-43
23. Slevin M., Kumar S., and Gaffney J. Angiogenic oligosaccharides of hyaluronan induce multiple signalling pathways affecting vascular endothelial cell mitogenic and wound healing responses. J. Biol. Chem. 277 (2002) 41046-41059
24. Paget C., Lecomte M., Ruggiero D., Wiernsperger N., and Lagarde M. Modification of enzymatic antioxidants in retinal microvascular cells by glucose or advanced glycation end products. Free Radic. Biol. Med. 25 (1998) 121-129
25. Padayatti P.S., Jiang C., Glomb M.A., Uchida K., and Nagaraj R.H. High concentrations of glucose induce synthesis of argpyrimidine in retinal endothelial cells. Curr. Eye Res. 23 (2001) 106-115
26. Mullokandov E.A., Franklin W.A., and Brownlee M. DNA damage by the glycation products of glyceraldehyde-3-phosphate and lysine. Diabetologia 37 (1994) 145-149
27. Levi B., and Werman M.J. Fructose triggers DNA modification and damage in an Escherichia coli plasmid. J. Nutr. Biochem. 12 (2001) 235-241
28. Giardino I., Edelstein D., and Brownlee M. Non enzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. J. Clin. Invest. 94 (1994) 110-117
29. Duraisamy Y., Slevin M., Smith N., Bailey J., Zweit J., Smith C., Ahmed N., and Gaffney J. Effect of glycation on basic fibroblast growth factor induced angiogenesis and activation of associated signal transduction pathways in vascular endothelial cells: possible relevance to wound healing in diabetes. Angiogenesis 4 (2001) 277-288
30. Chibber R., Molinatti P.A., Rosatto N., Lambourne B., and Kohner E.M. Toxic action of advanced glycation endproducts on cultured retinal capillary pericytes and endothelial cells: relevance to diabetic retinopathy. Diabetologia 43 (1997) 156-164
31. Koschinsky T., He C.J., Mitsuhashi T., Bucala R., Liu C., Buenting C., Heitmann K., and Vlassara H. Orally absorbed reactive glycation products (glycotoxins) an environmental risk factor in diabetic nephropathy. Proceedings of the National Academy of Sciences USA vol. 94 (1997) 6474-6479
32. Cerami C., Founds H., Nicholl I., Mitsuhashi T., Giordano D., Vanpatten S., Lee A., Al-Abed Y., Vlassara H., and Cerami A. Tobacco smoke is a source of toxic reactive glycation products. Proceedings of the National Academy of Sciences USA vol. 94 (1997) 13915-13920
33. Peppa M., Brem H., Ehrlich P., Zhang J.-G., Cai W., Li Z., Croitoru A., Thung S., and Vlassara H. Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice. Diabetes 52 (2003) 2805-2813
34. Ceriello A., Giugliano D., Quatraro A., Dello Russo P., and Torella R. A preliminary note on inhibiting effect of α-tocopherol (vitamin E) on protein glycation. Diabetes Metab. (Paris) 14 (1988) 40-42
35. Jain S.K., and Palmer M. The effect of oxygen radical metabolites and vitamin E on glycosylation of proteins. Free Radic. Biol. Med. 22 (1997) 593-596
36. Jain S.K., McVie R., Jaramillo J.J., Palmer M., and Smith T. The effect of modest vitamin E supplementation on blood glycated haemoglobin and triglyceride levels and red cell indices in type 1 diabetic patients. J. Am. Coll. Nutr. 15 (1996) 458-461
37. Crabbe M.J.C., Ustundag B., Cay M., Naziroglu M., Ilhan N., Ozercan I.H., and Dilsiz N. Effects of vitamin E on serum glucose levels and nephropathy in streptozotocin-diabetic rats. In: O'Brien J., Nursten H.E., Crabbe M.J.C., and Ames J.M. (Eds). The Maillard Reaction in Foods and Medicine (1998), The Royal Society of Chemistry, Cambridge 268-272
38. Giardino I., Edelstein D., and Brownlee M. BCL-2 expression or antioxidants prevent hyperglycaemia induced formation of intracellular advanced glycation end products in bovine endothelial cells. J. Clin. Invest. 97 (1996) 1422-1428
39. Jain S.K., Palmer M., and Chen Y. Effect of vitamin E and N-acetylcysteine on phospatidylserine externalization and induction of coagulation by high-glucose-treated human erythrocytes. Metabolism 48 (1999) 957-959
40. Jaine S.K., McVie R., and Smith T. Vitamin E supplement restores glutathione and malondialdehyde to normal concentrations in erythrocytes of type 1 diabetic children. Diabetes Care 23 (2000) 1389-1394
41. McPherson J.D., Shilton B.H., and Walton D.J. Role of fructose in glycation and cross-linking of proteins. Biochemistry 27 (1988) 1901-1907
42. Shangari N., and O'Brien P.J. The cytotoxic mechanism of glyoxal involves oxidative stress. Biochem. Pharmacol. 68 (2004) 1433-1442
43. Szwergold B.S. alpha-Thiolamines such as cysteine and cysteamine act as effective transglycating agents due to formation of irreversible thiazolidine derivatives. Med. Hypotheses (2005) 698-707
44. Cherian M., and Abraham E.C. Glycation of human lens crystalline: effect of age and aspirin treatment. Ophthalm. Res. 25 (1993) 349-354
45. Malik N.S., and Meek K.M. The inhibition of sugar-induced structural alterations in collagen by aspirin and other compounds. Biochem. Biophys. Res. Commun. 199 (1994) 683-686
46. Exner M., Hermann M., Hofbauer R., Kapiotis S., Speiser W., Held I., Seelos C., and Gmeimer B.M. The salicylate metabolite gentisic acid, but not the parent drug, inhibits glucose autooxidation-mediated atherogenic modification of low density lipoprotein. FEBS Lett. 470 (2000) 47-50
47. La Selva M., Molinatti P., Porta M., and Molinatti G.M. Aspirin and salicylate do not modify impaired endothelial cell replication at high glucose concentrations. Diabetes Res. 8 (1988) 49-50